NCT02854072 2016-11-22
A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients
Samsung Pharmaceutical Co., Ltd.
Phase 3 Unknown
Clinical Trials
6 trialsNCT01247623 2014-11-05
Trial With Telomerase Peptide Vaccine In Combination With Temozolomide in Patients With Advanced Malignant Melanoma
Oslo University Hospital
Phase 1/2 Completed
NCT01579188 2012-04-19
LucaVax
Kael-GemVax Co., Ltd.
Phase 3 Unknown
NCT01223209 2012-01-11
A Study, Combination, Immunologic Study of LTX-315 as Adjunct to GV1001 in Patients Following Curative Surgery for Carcinoma
Lytix Biopharma AS
Phase 1 Completed
NCT00444782 2008-12-18
A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma.
Pharmexa A/S
Phase 2 Completed
NCT00358566 2008-05-19
GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer
Pharmexa A/S
Phase 3 Terminated